Targeting the tick protective antigen subolesin reduces vector infestations and pathogen infection by Anaplasma marginale and Babesia bigemina

Vaccine

Volumn 29, Issue 47, 2011, Pages 8575-8579

  Merino, Octavio ^a,b   Almazán, Consuelo ^b   Canales, Mario ^a   Villar, Margarita ^a   Moreno Cid, Juan A ^a   Galindo, Ruth C ^a   De la Fuente, José ^a,c  

^a INSTITUTO DE INVESTIGACIÓN EN RECURSOS CINEGÉTICOS IREC CSIC UCLM JCCM   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE TAMAULIPAS   (Mexico)

^c OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Akirin; Boophilus; Cattle tick; RNA interference; Subolesin; Vaccine; Vector

Indexed keywords

ANTIGEN; MESSENGER RNA; SUBOLESIN; UNCLASSIFIED DRUG;

ANAPLASMA MARGINALE; ANAPLASMOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABESIA BIGEMINA; BABESIOSIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE INACTIVATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA INTERFERENCE; TICK INFESTATION;

ANAPLASMA MARGINALE; ANIMALS; ANTIGENS; ARTHROPOD PROTEINS; BABESIA; CATTLE; FEMALE; GENE EXPRESSION PROFILING; POLYMERASE CHAIN REACTION; RHIPICEPHALUS; TICK INFESTATIONS;

EID: 82455192375     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.09.023     Document Type: Article

References (41)

1. Jones K.E., Patel N.G., Levy M.A., Storeygard A., Balk D., Gittleman J.L., et al. Global trends in emerging infectious diseases. Nature 2008, 451:990-994.
2. Peter R.J., Van den Bossche P., Penzhorn B.L., Sharp B. Tick, fly, and mosquito control-lessons from the past, solutions for the future. Vet Parasitol 2005, 132:205-215.
3. Barker S.C., Murrell A. Systematics and evolution of ticks with a list of valid genus and species names. Parasitology 2004, 129:S15-S36.
4. Estrada-Peña A., Bouattour A., Camicas J.L., Guglielmone A., Horak I., Jongejan F., et al. The known distribution and ecological preferences of the tick subgenus Boophilus (Acari: Ixodidae) in Africa and Latin America. Exp Appl Acarol 2006, 38:219-235.
5. Olwoch J.M., Van Jaarsveld A.S., Scholtz C.H., Horak I.G. Climate change and the genus Rhipicephalus (Acari: Ixodidae) in Africa. Onderstepoort J Vet Res 2007, 74:45-72.
6. Perez de Leon A.A., Strickman D.A., Knowles D.P., Fish D., Thacker E., de la Fuente J., et al. One health approach to identify research needs in bovine and human babesioses: workshop report. Parasit Vectors 2010, 3:36.
7. Madder M., Thys E., Achi L., Touré A., De Deken R. Rhipicephalus (Boophilus) microplus: a most successful invasive tick species in West-Africa. Exp Appl Acarol 2011, 53:139-145.
8. Graf J.F., Gogolewski R., Leach-Bing N., Sabatini G.A., Molento M.B., Bordin E.L., et al. Tick control: an industry point of view. Parasitology 2004, 129:S427-S442.
9. de la Fuente J., Kocan K.M. Strategies for development of vaccines for control of ixodid tick species. Parasite Immunol 2006, 28:275-283.
10. de la Fuente J., Moreno-Cid J.A., Canales M., Villar M., Pérezde la Lastra J.M., Kocan K.M., et al. Targeting arthropod subolesin/akirin for thedevelopment of a universal vaccine for control of vector infestations andpathogen transmission. Vet Parasitol 2011, 181:17-22.
11. Willadsen P. Tick control: thoughts on a research agenda. Vet Parasitol 2006, 138:161-168.
12. de la Fuente J., Almazán C., Canales M., Pérez de la Lastra J.M., Kocan K.M., Willadsen P. A ten-year review of commercial vaccine performance for control of tick infestations on cattle. Anim Health Res Rev 2007, 8:23-28.
13. de la Fuente J., Rodríguez M., Redondo M., Montero C., García-García J.C., Méndez L., et al. Field studies and cost-effectiveness analysis of vaccination with Gavac™ against the cattle tick Boophilus microplus. Vaccine 1998, 16:366-373.
14. de la Fuente J., Kocan K.M. Advances in the identification and characterization of protective antigens for development of recombinant vaccines against tick infestations. Expert Rev Vaccines 2003, 2:583-593.
15. Rodríguez Valle M., Méndez L., Valdez M., Redondo M., Espinosa C.M., Vargas M., et al. Integrated control of Boophilus microplus ticks in Cuba based on vaccination with the anti-tick vaccine Gavac. Exp Appl Acarol 2004, 34:375-382.
16. Almazán C., Kocan K.M., Bergman D.K., Garcia-Garcia J.C., Blouin E.F., de la Fuente J. Identification of protective antigens for the control of Ixodes scapularis infestations using cDNA expression library immunization. Vaccine 2003, 21:1492-1501.
17. de la Fuente J., Almazán C., Blas-Machado U., Naranjo V., Mangold A.J., Blouin E.F., et al. The tick protective antigen, 4D8, is a conserved protein involved in modulation of tick blood ingestion and reproduction. Vaccine 2006, 24:4082-4095.
18. Nijhof A.M., Taoufik A., de la Fuente J., Kocan K.M., de Vries E., Jongejan F. Gene silencing of the tick protective antigens, Bm86, Bm91 and subolesin, in the one-host tick Boophilus microplus by RNA interference. Int J Parasitol 2007, 37:653-662.
19. Almazán C., Lagunes R., Villar M., Canales M., Rosario-Cruz R., Jongejan F., et al. Identification and characterization of Rhipicephalus (Boophilus) microplus candidate protective antigens for the control of cattle tick infestations. Parasitol Res 2010, 106:471-479.
20. Almazán C., Blas-Machado U., Kocan K.M., Yoshioka J.H., Blouin E.F., Mangold A.J., et al. Characterization of three Ixodes scapularis cDNAs protective against tick infestations. Vaccine 2005, 23:4403-4416.
21. Merino O., Almazán C., Canales M., Villar M., Moreno-Cid J.A., Estrada-Peña A., et al. Control of Rhipicephalus (Boophilus) microplus infestations by the combination of subolesin vaccination and tick autocidal control after subolesin gene knockdown in ticks fed on cattle. Vaccine 2011, 29:2248-2254.
22. de la Fuente J., Manzano-Roman R., Naranjo V., Kocan K.M., Zivkovic Z., Blouin E.F., et al. Identification of protective antigens by RNA interference for control of the lone star tick, Amblyomma americanum. Vaccine 2010, 28:1786-1795.
23. Kocan K.M., Manzano-Roman R., de la Fuente J. Transovarial silencing of the subolesin gene in three-host ixodid tick species after injection of replete females with subolesin dsRNA. Parasitol Res 2007, 100:1411-1415.
24. de la Fuente J., Almazán C., Blouin E.F., Naranjo V., Kocan K.M. Reduction of tick infections with Anaplasma marginale and A. phagocytophilum by targeting the tick protective antigen subolesin. Parasitol Res 2006, 100:85-91.
25. de la Fuente J., Maritz-Olivier C., Naranjo V., Ayoubi P., Nijhof A.M., Almazán C., et al. Evidence of the role of tick subolesin in gene expression. BMC Genomics 2008, 9:372.
26. Kocan K.M., Zivkovic Z., Blouin E.F., Naranjo V., Almazán C., Mitra R., et al. Silencing of genes involved in Anaplasma marginale-tick interactions affects the pathogen developmental cycle in Dermacentor variabilis. BMC Dev Biol 2009, 9:42.
27. Galindo R.C., Doncel-Pérez E., Zivkovic Z., Naranjo V., Gortazar C., Mangold A.J., et al. Tick subolesin is an ortholog of the akirins described in insects and vertebrates. Dev Comp Immunol 2009, 33:612-617.
28. Mangold AJ, Galindo RC, de la Fuente J. Response to the commentary of D. Macqueen on: Galindo RC, Doncel-Pérez E, Zivkovic Z, Naranjo V, Gortazar C, Mangold AJ, et al. Tick subolesin is an ortholog of the akirins described in insects and vertebrates [Dev. Comp. Immunol. 33;2009:612-617]. Dev Comp Immunol 2009;33:878-879.
29. Zivkovic Z., Torina A., Mitra R., Alongi A., Scimeca S., Kocan K.M., et al. Subolesin expression in response to pathogen infection in ticks. BMC Immunol 2010, 11:7.
30. Goto A., Matsushita K., Gesellchen V., El Chamy L., Kuttenkeuler D., Takeuchi O., et al. Akirins are highly conserved nuclear proteins required for NF-kappaB-dependent gene expression in drosophila and mice. Nat Immunol 2008, 9:97-104.
31. Labuda M., Trimnell A.R., Ličková M., Kazimírová M., Davies G.M., Lissina O., et al. An antivector vaccine protects against a lethal vector-borne pathogen. PLoS Pathog 2006, 2(4):e27.
32. Fragoso-Sanchez H., Garcia-Vazquez Z., Tapia-Perez G., Ortiz-Najera A., Rosario-Cruz R., Rodriguez-Vivas I. Response of Mexican Rhipicephalus (Boophilus) microplus ticks to selection by amitraz and genetic analysis of attained resistance. J Entomol 2011, 8:218-228.
33. Mosqueda J., Ramos J.A., Falcon A., Alvarez J.A., Aragon V., Figueroa J.V. Babesia bigemina: sporozoite isolation from Boophilus microplus nymphs and initial immunomolecular characterization. Ann N Y Acad Sci 2004, 1026:222-231.
34. de la Fuente J., Kocan K.M., Almazán C., Blouin E.F. RNA interference for the study and genetic manipulation of ticks. Trends Parasitol 2007, 23:427-433.
35. de la Fuente J., Blouin E.F., Manzano-Roman R., Naranjo V., Almazán C., Perez de la Lastra J.M., et al. Functional genomic studies of tick cells in response to infection with the cattle pathogen, Anaplasma marginale. Genomics 2007, 90:712-722.
36. Cobon G., Hungerford J., Woodrow M., Smith D., Willadsen P. Vaccination against Boophilus microplus. The Australian field experience. Recombinant vaccines for the control of cattle tick 1995, 163-176. Elfos Scientiae, La Habana, Cuba. J. de la Fuente (Ed.).
37. Bastos R.G., Ueti M.W., Knowles D.P., Scoles G.A. The Rhipicephalus (Boophilus) microplus Bm86 gene plays a critical role in the fitness of ticks fed on cattle during acute Babesia bovis infection. Parasit Vectors 2010, 3:111.
38. Canales M., Naranjo V., Almazán C., Molina R., Tsuruta S.A., Szabó M.P.J., et al. Conservation and immunogenicity of the mosquito ortholog of the tick protective antigen, subolesin. Parasitol Res 2009, 105:97-111.
39. Harrington D., Canales M., de la Fuente J., de Luna C., Robinson K., Guy J., et al. Immunisation with recombinant proteins subolesin and Bm86 for the control of Dermanyssus gallinae in poultry. Vaccine 2009, 27:4056-4063.
40. Moreno-Cid J.A., Jiménez M., Cornelie S., Molina R., Alarcón P., Lacroix M.-N., et al. Characterization of Aedes albopictus akirin for the control of mosquito and sand fly infestations. Vaccine 2011, 29:77-82.
41. Prudencio C.R., Pérez de la Lastra J.M., Canales M., Villar M., de la Fuente J. Mapping protective epitopes in the tick and mosquito subolesin ortholog proteins. Vaccine 2010, 28:5398-5406.